A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model
- PMID: 22276591
- PMCID: PMC3310481
- DOI: 10.3109/10408444.2011.636342
A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model
Abstract
Mycotoxins, such as ochratoxin A (OTA), can occur from fungal growth on foods. OTA is considered a possible risk factor for adverse renal effects in humans based on renal tumors in male rats. For risk mitigation, Health Canada proposed maximum limits (MLs) for OTA based largely on a comparative risk assessment conducted by Health Canada (Kuiper-Goodman et al., 2010), in which analytical data of OTA in foods were used to determine the possible impact adopting MLs may have on OTA risks. The EU MLs were used for comparison and resultant risk was determined based on age-sex strata groups. These data were reevaluated here to determine comparative risk on a lifetime basis instead of age strata. Also, as there is scientific disagreement over the mechanism of OTA-induced renal tumors, mechanistic data were revisited. On a lifetime basis, risks associated with dietary exposure were found to be negligible, even without MLs, with dietary exposures to OTA three to four orders of magnitude below the pivotal animal LOAEL and the TD(05). Our review of the mechanistic data supported a threshold-based mechanism as the most plausible. In particular, OTA was negative in genotoxicity assays with the highest specificity and levels of DNA adducts were very low and not typical of genotoxic carcinogens. In conclusion, OTA exposures from Canadian foods do not present a significant cancer risk.
References
-
- Adler M, Müller K, Rached E, Dekant W, Mally A. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis. 2009;30:711–719. - PubMed
-
- Ali R, Mittelstaedt RA, Shaddock JG, Bhalli JA, Heflich RH. Micronucleus induction by ochratoxin A in CH9 and TK6 cells. Environ Mol Mutagen. 2010;51:728. abstract P78.
-
- Arbillaga L, Azqueta A, van Delft JH, López de Cerain A. In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. Toxicol Appl Pharmacol. 2007;220:216–224. - PubMed
-
- Arlt VM, Stiborová M, vom Brocke J, Simões ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis. 2007;28:2253–2261. - PubMed
-
- Auffray Y, Boutibonnes P. Evaluation of the genotoxic activity of some mycotoxins using Escherichia coli in the SOS spot test. Mutat Res. 1986;171:79–82. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical